Biofrontera Warrants Financials
| BFRIW Stock | USD 0.06 0 1.69% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.21 | 1.2757 |
|
|
Investors should never underestimate Biofrontera Warrants' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Biofrontera Warrants' cash flow, debt, and profitability to make informed and accurate decisions about investing in Biofrontera Warrants.
Net Income |
|
Biofrontera | Select Account or Indicator |
Understanding current and past Biofrontera Warrants Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biofrontera Warrants' financial statements are interrelated, with each one affecting the others. For example, an increase in Biofrontera Warrants' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Biofrontera Warrants' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biofrontera Warrants. Check Biofrontera Warrants' Beneish M Score to see the likelihood of Biofrontera Warrants' management manipulating its earnings.
Biofrontera Warrants Stock Summary
Biofrontera Warrants competes with Biofrontera, Inspira Technologies, and Bluejay Diagnostics. Biofrontera Warrants is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 09077D118 |
| Location | Massachusetts; U.S.A |
| Business Address | 120 Presidential Way, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.biofrontera-us.com |
| Phone | 781 245 1325 |
| Currency | USD - US Dollar |
Biofrontera Warrants Key Financial Ratios
| Return On Equity | -1.49 | ||||
| Profit Margin | (0.38) % | ||||
| Operating Margin | (0.65) % | ||||
| Revenue | 34.07 M | ||||
| EBITDA | (18.45 M) |
Biofrontera Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biofrontera Warrants's current stock value. Our valuation model uses many indicators to compare Biofrontera Warrants value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biofrontera Warrants competition to find correlations between indicators driving Biofrontera Warrants's intrinsic value. More Info.Biofrontera Warrants is rated fifth in return on equity category among its peers. It is rated third in return on asset category among its peers . At this time, Biofrontera Warrants' Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Biofrontera Warrants by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Biofrontera Warrants Systematic Risk
Biofrontera Warrants' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Biofrontera Warrants volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Biofrontera Warrants correlated with the market. If Beta is less than 0 Biofrontera Warrants generally moves in the opposite direction as compared to the market. If Biofrontera Warrants Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Biofrontera Warrants is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Biofrontera Warrants is generally in the same direction as the market. If Beta > 1 Biofrontera Warrants moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Biofrontera Warrants is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Biofrontera has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Biofrontera Warrants' financials are consistent with your investment objective using the following steps:- Review Biofrontera Warrants' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Biofrontera Warrants' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Biofrontera Warrants' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Biofrontera Warrants' stock is overvalued or undervalued.
Today, most investors in Biofrontera Warrants Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Biofrontera Warrants' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Biofrontera Warrants growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Biofrontera Warrants November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biofrontera Warrants help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biofrontera Warrants. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biofrontera Warrants based on widely used predictive technical indicators. In general, we focus on analyzing Biofrontera Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biofrontera Warrants's daily price indicators and compare them against related drivers.
| Downside Deviation | 28.07 | |||
| Information Ratio | 0.1252 | |||
| Maximum Drawdown | 452.55 | |||
| Value At Risk | (35.53) | |||
| Potential Upside | 77.27 |
Additional Tools for Biofrontera Stock Analysis
When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.